E. ALADAĞ KARAKULAK Et Al. , "CD34+hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.50, no.8, pp.1851-1856, 2020
ALADAĞ KARAKULAK, E. Et Al. 2020. CD34+hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.50, no.8 , 1851-1856.
ALADAĞ KARAKULAK, E., DEMİROĞLU, H., BÜYÜKAŞIK, Y., Turgut, M., AKSU, S., SAYINALP, N., ... HAZNEDAROĞLU, İ. C.(2020). CD34+hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.50, no.8, 1851-1856.
ALADAĞ KARAKULAK, ELİFCAN Et Al. "CD34+hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.50, no.8, 1851-1856, 2020
ALADAĞ KARAKULAK, ELİFCAN A. Et Al. "CD34+hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.50, no.8, pp.1851-1856, 2020
ALADAĞ KARAKULAK, E. Et Al. (2020) . "CD34+hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.50, no.8, pp.1851-1856.
@article{article, author={ELİFCAN ALADAĞ KARAKULAK Et Al. }, title={CD34+hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2020, pages={1851-1856} }